SMS Pharmaceuticals Ltd — Capital/Financing Update 2024

Mar 19, 2024

==> picture [241 x 158] intentionally omitted <==

Date: 19[th] March, 2024

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Allotment of 90,00,000 Warrants on preferential basis by way of a private placement. Ref: Our intimation dated 08[th] February, 2024 and 06[th] March, 2024.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and reference to the approval of the Board of Directors at its meeting dated 08[th] February, 2024 and approval of the Shareholders of the Company at the Extra-Ordinary General Meeting held on 06[th] March, 2024, we would like to inform you that the Securities Allotment Committee of Board of Directors of SMS Pharmaceuticals Limited (“Company”) at its meeting held today i.e. 19[th] March, 2024, has approved the allotment of warrants of the Company, on preferential basis by way of a private placement, as per the details set forth below:

Sr.No.	Name of theallottees	Category	No.ofwarrantAllotted	Priceatwhich thewarrantsareissued (in₹)(perwarrant)	Paid-upvalueperwarrant (in₹) at least25% of thepriceatwhichthewarrants areissued)	Considerationreceivedason the dateof allotment(in ₹)
1.	Ramesh BabuPotluri	Promoter/PromoterGroup	25,00,000	127	31.75	7,93,75,000
2.	Vamsi KrishnaPotluri	Promoter/PromoterGroup	25,00,000	127	31.75	7,93,75,000

==> picture [241 x 158] intentionally omitted <==

3.	Trilok Potluri	Promoter/PromoterGroup	25,00,000	127	31.75	7,93,75,000
4.	PotluriInfraProjects LLP	Promoter/PromoterGroup	15,00,000	127	31.75	4,76,25,000

Each of the Warrant, so allotted, is convertible in one or more tranches into or exchangeable for one fully paid-up equity share of face value of Rs.1/- (Rupee one only) of the Company in accordance with the provisions of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, on payment of the balance consideration (being 75% of the issue price per warrant) from the Allottees at the time of allotment of equity shares pursuant to exercise of conversion option against each such warrant.

The equity shares issued upon conversion of the warrants so issued shall rank pari passu to the existing fully paid-up equity shares of the Company and will be listed on BSE Limited and the National Stock Exchange of India Limited.

Kindly take the same on records.

Thanking you

Yours Faithfully

For SMS Pharmaceuticals Limited

THIRUMA Digitally signed by THIRUMALESH LESH TUMMA Date: 2024.03.19 TUMMA 12:15:37 +05'30' Thirumalesh Tumma Company Secretary